Professor of Pediatrics
Harvard Medical School
Chief, Division of Immunology
Boston Children’s Hospital
Director, Center for Adults with Pediatric Rheumatic Illness (CAPRI)
Brigham and Women’s Hospital
Dr. Peter Nigrovic is a pediatric and adult rheumatologist whose research focuses on understanding mechanisms of inflammatory arthritis and lupus, using both human samples and mouse models. These studies have helped to illuminate the roles played by mast cells, neutrophils and platelets, among other cell types. In studies supported by ANRF, his group has identified a new pathway by which entry of neutrophils could potentially be targeted to treat inflammatory arthritis, and is pursuing the role of sugars (glycans) attached to antibodies that alter their ability to engage the immune system. He is Chief of the Division of Immunology at Boston Children’s Hospital and maintains biorepositories of arthritis samples at Boston Children’s Hospital and the Brigham and Women’s Hospital. Dr. Nigrovic earned his M.D. at Harvard Medical School in 1995 and his research was funded by grants from the ANRF to Dr. Nigrovic and affiliated researchers since 2009.
He serves on the editorial board of Arthritis & Rheumatology and in the leadership of the US/Canadian pediatric research collaborative CARRA (the Childhood Arthritis and Rheumatology Research Alliance). He is an award-winning mentor for junior scientists and was founding co-chair of AMIGO, the American College of Rheumatology’s inter-institutional mentoring program in pediatric rheumatology. Dr. Nigrovic has a particular interest in systemic juvenile idiopathic arthritis and on the lifelong care of arthritis beginning in childhood.